The present disclosure relates to implantable, expandable prosthetic devices and to methods and apparatuses for such prosthetic devices.
The human heart can suffer from various valvular diseases. These valvular diseases can result in significant malfunctioning of the heart and ultimately require replacement of the native valve with an artificial valve. There are several known artificial valves and several known methods of implanting these artificial valves in humans. Because of the drawbacks associated with conventional open-heart surgery, percutaneous and minimally-invasive surgical approaches are garnering intense attention. In one technique, a prosthetic heart valve is configured to be implanted in a much less invasive procedure by way of catheterization. For example, collapsible transcatheter prosthetic heart valves can be compressed and percutaneously introduced in the compressed state with a delivery apparatus and expanded to a functional size at the desired position. A challenge in transcatheter prosthetic heart valves is control of perivalvular leakage around the valve, which can occur for a period of time following initial implantation.
Disclosed herein are exemplary embodiments of prosthetic heart valves with sealing members. The sealing members can, for example, reduce and/or eliminate perivalvular leakage.
In one representative embodiment, a prosthetic heart valve can comprise a frame, a valve component, and a sealing member.
In some embodiments, the frame can have an inflow end portion, an outflow end portion, an intermediate portion disposed between the inflow and outflow end portions, and a plurality of struts. The frame can be radially compressible and expandable between a radially-compressed configuration and a radially-expanded configuration.
In some embodiments, the valve component can be disposed within and coupled to the frame and have a plurality of leaflets.
In some embodiments, the sealing member can have a plurality of ribs and a plurality of drapes. The ribs can be coupled to and extend radially outwardly from the frame when the frame is in the radially-expanded configuration. The drapes can be coupled to and extend radially between the frame and the ribs. The sealing member can be configured to reduce or prevent perivalvular leakage around the prosthetic heart valve.
In some embodiments, each of the ribs includes a first end portion connected to the inflow end portion of the frame and a second end portion connected to the intermediate portion of the frame.
In particular embodiments, the struts of the frame form rows of junctions where the struts are connected to each other, the first end portions of the ribs are connected to one row of junctions, and the second end portions of the ribs are connected to another row of junctions spaced from the one row of junctions.
In certain embodiments, the first end portion of each rib is circumferentially offset relative to the second end portion of the rib when the prosthetic heart valve is in the radially-expanded configuration.
In some embodiments, the first end portions of adjacent ribs are coupled to a first apex of the frame, and the second end portions of the adjacent ribs are coupled to a second apex of the frame.
In one particular embodiment, the ribs of the sealing member are coupled together in a zig-zag or undulating pattern extending circumferentially around the frame.
In some embodiments, the prosthetic heart valve further comprises a plurality of flexible cords connected to and extending between the frame and the ribs of the sealing member.
In certain embodiments, the cords are connected to the ribs at intermediate portions of the ribs disposed between the first and second end portions of the ribs.
In some embodiments, the prosthetic heart valve further comprises a skirt mounted on the frame, and the drapes have inner longitudinally-extending edges sutured to the skirt and outer longitudinally-extending edges secured to the ribs.
In particular embodiments, the drapes of the sealing member are first drapes, and the sealing member further comprises a plurality of second drapes that are coupled to the frame and the ribs and that are circumferentially disposed between adjacent ribs and the first drapes.
In some embodiments, the ribs and the drapes extend longitudinally along the frame.
In certain embodiments, the drapes comprise PET, PTFE, ePTFE, polyurethane, or polyester.
In some embodiments, the frame is at least partially self-expandable from the radially-compressed configuration to the radially-expanded configuration.
In certain embodiments, the frame is at least partially mechanically expandable from the radially-compressed configuration to the radially-expanded configuration.
In another representative embodiment, a prosthetic heart valve can comprise a frame, a valve component, and a sealing member. The sealing member can include a plurality of ribs, a plurality of first drapes, and a plurality of second drapes. The ribs can be coupled to and extend radially outwardly from the frame when the frame is in the radially-expanded configuration. The first drapes can be coupled to the frame and the ribs, be circumferentially aligned with the ribs, and radially extend between the frame and the ribs. The second drapes can be coupled to the frame, the ribs, and the first drapes.
In some embodiments, each of the first drapes is connected to a respective rib, and each of the second drapes extends circumferentially between adjacent ribs.
In particular embodiments, the ribs and the first drapes extend longitudinally along the frame.
In one embodiment, the first drapes extend from the frame in a first plane, and the second drapes extend from the frame in a second plane that is at least substantially perpendicular to the first plane.
In some embodiments, the prosthetic heart valve further comprises a plurality of flexible cords that are coupled to and extend between the frame and the ribs, and the second drapes are mounted to the cords.
In yet another representative embodiment, a prosthetic heart valve can comprise a frame, a valve component, and a sealing member. The sealing member can include a plurality of ribs, a plurality of drapes, and one or more cords. The ribs can be coupled to and extend radially outwardly from the frame when the frame is in the radially-expanded configuration. The drapes can be coupled to and extend radially between the frame and the ribs. The cords can be coupled to the frame and the ribs so as to limit radial expansion of the ribs relative to the frame. The sealing member can be configured to reduce or prevent perivalvular leakage around the prosthetic heart valve.
The various innovations of this disclosure can be used in combination or separately. This summary is provided to introduce a selection of concepts in a simplified form that are further described below in the detailed description. This summary is not intended to identify key features or essential features of the claimed subject matter, nor is it intended to be used to limit the scope of the claimed subject matter. The foregoing and other objects, features, and advantages of the disclosure will become more apparent from other portions of this disclosure, including the detailed description, drawings, claims, and abstract.
General Considerations
For purposes of this description, certain aspects, advantages, and novel features of the embodiments of this disclosure are described herein. The disclosed methods, apparatus, and systems should not be construed as being limiting in any way. Instead, the present disclosure is directed toward all novel and nonobvious features and aspects of the various disclosed embodiments, alone and in various combinations and sub-combinations with one another. The methods, apparatus, and systems are not limited to any specific aspect or feature or combination thereof, nor do the disclosed embodiments require that any one or more specific advantages be present or problems be solved.
Although the operations of some of the disclosed embodiments are described in a particular, sequential order for convenient presentation, it should be understood that this manner of description encompasses rearrangement, unless a particular ordering is required by specific language set forth below. For example, operations described sequentially may in some cases be rearranged or performed concurrently. Moreover, for the sake of simplicity, the attached figures may not show the various ways in which the disclosed methods can be used in conjunction with other methods. Additionally, the description sometimes uses terms like “provide” or “achieve” to describe the disclosed methods. These terms are high-level abstractions of the actual operations that are performed. The actual operations that correspond to these terms may vary depending on the particular implementation and are readily discernible by one of ordinary skill in the art.
As used in this application and in the claims, the singular forms “a,” “an,” and “the” include the plural forms unless the context clearly dictates otherwise. Additionally, the term “includes” means “comprises.” Further, the term “coupled” generally means physically, mechanically, chemically, magnetically, and/or electrically coupled or linked and does not exclude the presence of intermediate elements between the coupled or associated items absent specific contrary language.
As used herein, the term “proximal” refers to a position, direction, or portion of a device that is closer to the user and further away from the implantation site. As used herein, the term “distal” refers to a position, direction, or portion of a device that is further away from the user and closer to the implantation site. Thus, for example, proximal motion of a device is motion of the device away from the implantation site and toward the user (e.g., out of the patient's body), while distal motion of the device is motion of the device away from the user and toward the implantation site (e.g., into the patient's body). The terms “longitudinal” and “axial” refer to an axis extending in the proximal and distal directions, unless otherwise expressly defined.
As used herein, the terms “integrally formed” and “unitary construction” refer to a construction that does not include any welds, fasteners, or other means for securing separately formed pieces of material to each other.
As used herein, the term “approximately” means the listed value and any value that is within 10% of the listed value. For example, “approximately 100 degrees” means any angle between 90-110 degrees, inclusive.
Disclosed herein are exemplary embodiments of prosthetic heart valves with sealing members. The sealing members can, for example, reduce and/or eliminate perivalvular leakage (“PVL”).
In some embodiments, a sealing member can comprise one or more ribs that extend radially outwardly from a frame of the prosthetic heart valve. In certain embodiments, the sealing member further comprises one or more drapes extending radially between the ribs and the frame.
In particular embodiments, the ribs and/or the drapes are flexible such the sealing member can conform to the anatomy of a native heart valve annulus. In this manner, the sealing member can reduce and/or eliminate PVL between a prosthetic heart valve and the native annulus.
In some embodiments, a sealing member can include a plurality of cords that are coupled to the ribs and the frame of the prosthetic heart valve. The cords can, for example, retain the position of the ribs relative to the frame.
In some embodiments, a sealing member can comprise first and second drapes. The first drapes can extend radially between the ribs and the frame of the prosthetic heart valve. The second drapes can be coupled to and extend radially outwardly from the frame and can extend circumferentially between the first drapes.
Referring to
The frame 102 can include a plurality of interconnected struts 116 arranged in a lattice-type pattern. The struts 116 can form a plurality of junctions 118 where the struts 116 intersect. The junctions 118 of the struts 116 disposed at the inflow and outflow end portions 110, 112 of the frame 102 can also be referred to as apices 119. The struts 116 are shown as positioned diagonally, or offset at an angle relative to, and radially offset from, the longitudinal axis of the prosthetic heart valve 100. In other embodiments and/or configurations, the struts 116 can be offset to a greater and/or lesser extent than depicted in
In some embodiments, the struts 116 can be pivotably coupled to one another. In the illustrated embodiment, for example, the struts 116 form respective hinges at the junctions 118. In certain embodiments, fasteners (e.g., rivets or pins) 120 can be used to pivotably couple the struts 116 together. The hinges can allow the struts 116 to pivot relative to one another as the frame 102 is expanded or contracted, such as during assembly, preparation, and/or implantation of the prosthetic heart valve 100. For example, the frame 102 (and thus the prosthetic heart valve 100) can be manipulated into a radially-compressed or contracted configuration (e.g.,
The frame 102 can be formed using any suitable technique. Suitable techniques can include separately forming individual components (e.g., the struts 116 and fasteners 120) of the frame 102 and then mechanically assembling and connecting the individual components to form the frame 102. The struts 116 and fasteners 120 can be formed, for example, by laser cutting those components from sheets or tubes of metal, or by electroforming (electroplating or electrodeposition) or physical vapor deposition. In some embodiments, electroforming or physical vapor deposition can be used to form subcomponents of the frame 102 or the entire frame 102 with pivotable connections between the struts 116. In one embodiment, for example, electroforming or physical vapor deposition can be used to form struts 116 having integral fasteners 120. The individual struts 116 can be assembled together into a frame by inserting the integral fasteners 120 of each strut through a corresponding aperture of an adjacent strut. In some embodiments, electroforming or physical vapor deposition can be used to form the entire frame 102 in its final, cylindrical shape. In other embodiments, electroforming or physical vapor deposition can be used to form the entire frame in a flattened configuration, after which the ends of the flattened frame are connected to each other to form the final cylindrical shape of the frame.
In other embodiments, the struts 116 are not coupled to each other with respective hinges (e.g., fasteners) but are otherwise pivotable or bendable relative to each other to permit radial expansion and contraction of the frame. For example, the frame 102 can be formed (e.g., via laser cutting, electroforming or physical vapor deposition) from a single piece of material (e.g., a metal tube).
The frame 102 can be made of any of various suitable materials, such as stainless steel or a nickel titanium alloy (“NiTi”), for example, nitinol.
Additional details regarding the frame 102 can be found, for example, in U.S. Application No. 62/430,810, filed Dec. 6, 2016, and U.S. Patent Application Publication No. 2018/0153689, which are incorporated by reference herein.
Returning to
As mentioned above, the skirt 106 can be mounted on the inside and/or outside of the frame 102. The skirt can be formed from natural tissue (e.g., pericardial tissue) or any of various biocompatible synthetic materials, including biocompatible fabrics (e.g., polyethylene terephthalate (“PET”) fabric). Additional details regarding the skirt 106, as well as the valve structure 104, can be found, for example, in U.S. Pat. No. 9,974,650, which is incorporated by reference herein.
The sealing member 108 can form a flexible structure that extends radially outwardly from the frame 102 of the prosthetic heart valve 100 when the prosthetic heart valve is in the radially-expanded configuration. As such, the sealing member 108 can, for example, conform to the anatomy of a native annulus and restrict or block blood flow around the prosthetic heart valve 100, thereby eliminating or reducing PVL.
The sealing member 108 can comprise a plurality of ribs 124 and a plurality of drapes 126, which can also be referred to as “connectors.” As shown in
The ribs 124 can be coupled to the frame 102 in various ways. For example, the ribs 124 and the frame 102 can be coupled by welding, fasteners (e.g., rivets, pins, screws), sutures, adhesive, and/or other suitable means for coupling.
Referring again to
In certain embodiments, the first and second end portions 128, 130 of the ribs 124 can be coupled to respective junctions 118 of the frame 102. For example, in the illustrated embodiment, the first end portions 128 are coupled to a first circumferential row of junctions (i.e., counting from the inflow end portion 110), and the second end portions 130 are coupled to a fourth circumferential row of junctions. In other embodiments, the first and/or second end portions 128, 130 can be coupled to various other rows of junctions.
In particular embodiments, the first end portion 128 of each rib 124 can be circumferentially offset relative to the respective second end portion 130 such that the ribs 124 are angled relative to the longitudinal axis of the prosthetic heart valve 100 when the prosthetic heart valve 100 is in the radially-expanded configuration. In some embodiments, the first end portions 128 of adjacent ribs 124 can be coupled to the frame 102 at or near the same location on the frame, and the second end portions 130 of adjacent ribs 124 can be coupled to the frame 102 at or near the same location on the frame. As such, the ribs 124 can, for example, form in a zig-zag or undulating pattern when the prosthetic heart valve 100 is in the radially-expanded configuration (e.g.,
The first and second end portions 128, 130 of the ribs 124 can be coupled to the frame 102 at locations in which the relative distance between the locations changes as the prosthetic heart valve moves between the radially-expanded/axially-foreshortened configuration and the radially-compressed/axially-elongated configuration.
The ribs 124 can be sized and configured such that the length of the ribs 124 between their opposing ends is longer than the straight-line distance between the locations at which the first and second end portions 128, 130 are attached to the frame 102 when the prosthetic heart valve 100 is in the radially-expanded configuration (e.g.,
The ribs 124 can also be sized and configured such that the length of the ribs 124 is equal or approximately equal to the distance between the locations at which the first and second end portions 128, 130 are attached to the frame 102 when the prosthetic heart valve 100 is in the radially-compressed configuration (e.g.,
The length of the ribs 124 and/or the location to which the ribs 124 are attached to the frame 102 can be sized and/or configured to adjust the extent to which the ribs 124 radially expand relative to the frame 102. For example, ribs having relatively longer length can expand farther radially outwardly than ribs having relatively shorter length (assuming they are attached to the frame at the same position relative to the longitudinal axis of the prosthetic heart valve 100).
In some embodiments, the ribs 124 can be sized and/or positioned relative to the frame 102 such that each of the ribs can radially expand equidistantly from the frame 102. This can be accomplished, for example, by forming each of the ribs 124 with the same length and coupling the ribs to the frame 102 at the same position relative to the longitudinal axis of the frame. It can also be accomplished, for example, by forming one or more of the ribs 124 with a different length than at least one other rib and coupling one or more of the ribs to the frame with different spacing between the first and second end portions 128, 130 than at least one other rib.
In other embodiments, one or more of the ribs 124 can be sized and/or positioned relative to the frame 102 such that one or more of the ribs can radially expand relatively more or less than at least one other rib. This can be accomplished, for example, by forming one or more of the ribs 124 with a different length than at least one other rib and coupling one or more of the ribs to the frame with different spacing between the first and second end portions 128, 130 than at least one other rib.
The ribs 124 can be formed from a resilient material such that the ribs 124 tend not to plastically deform when ribs compress and expand as the prosthetic heart valve 100 moves between the radially-expanded configuration and the radially-compressed configuration. This can be accomplished, for example, by forming the ribs from a relative flexible material such as nitinol, stainless steel, or a suitable biocompatible polymer.
Although the drapes 126 are shown in a mesh-like pattern for purposes of illustration, the drapes can comprise a tightly woven or sheet-like material. In some embodiments, the drapes 126 can comprise a flexible fabric or material configured to occlude or restrict blood flow, including PET, polytetrafluoroethylene (“PTFE”), expanded polytetrafluoroethylene (“ePTFE”), polyurethane, and/or polyester. In certain embodiments, the drapes 126 can be formed from the same material as the skirt 106 (e.g., PET). In other embodiments, the drapes 126 and the skirt 106 can be formed from different materials. For example, the drapes 126 can be formed from PTFE and the skirt 106 can be formed from polyester, or vice versa.
The drapes 126 can be coupled to the ribs 124 and/or the skirt 106 in various ways. For example, in some embodiments, each of the drapes 126 can be wrapped around a respective rib 124 and coupled to itself (e.g., with fasteners, sutures, adhesive, ultrasonic welding, and/or other suitable means for coupling). In other embodiments, the drapes 126 can be coupled to the ribs 124 without wrapping the drapes around the ribs. The drapes 126 can be coupled to the skirt 106, for example, with fasteners, sutures, adhesive, ultrasonic welding, and/or other suitable means for coupling. In one example, the edge 140 of each drape 126 can be sutures to the skirt 106 along the entire length of the edge 140, such as with a running stitch.
The drapes 126 can be sized and/or configured such that the drapes slacken and/or fold when the prosthetic heart valve 100 is compressed from the radially-expanded configuration to the radially-compressed configuration. This allows the ribs 124 to compress radially inwardly against the frame 102, and thus reduces the radial profile of the prosthetic heart valve in the radially-compressed configuration. The drapes 126 can also be sized and/or configured such that the drapes tighten and/or unfold when the prosthetic heart valve 100 is expanded from the radially-compressed configuration to the radially-expanded configuration.
Optionally, the sealing member 108 can further comprise a plurality of retaining members or cords 132. The cords 132 can be coupled to and extend from the frame 102 to the ribs 124. The cords 132 can, for example, be configured to retain the ribs 124 at a desired spacing and/or configuration relative to the frame 102.
The cords 132 can, for example, be coupled to the frame 102 and the ribs 124 at locations between the first and second end portions 128, 130 of the ribs. For example, in some embodiments, the cords 132 can be coupled to and extend from junctions 118 of the frame 102 that are disposed between the junctions to which the first and second end portions 128, 130 of the ribs 124 are attached.
In some embodiments, each rib 124 has two cords 132 coupled thereto. In other embodiments, each rib 124 can have more or less than two cords 132 coupled thereto. In some embodiments, there can be a single cord that is coupled to (e.g., wrapped around) all of the ribs 124 and to the frame 102.
The cords 132 can be formed from a relatively flexible, inelastic material such as nylon thread or stainless-steel wire. In this manner, the cords 132 can slacken and/or fold when the prosthetic heart valve 100 is crimped from the radially-expanded configuration to the radially-compressed configuration, and the cords can tighten and/or unfold when the prosthetic heart valve is expanded from the radially-compressed configuration to the radially-expanded configuration.
The length of the cords 132 can be sized and/or configured to control the extent to which the ribs 124 can radially expand relative to the frame 102. For example, cords 132 having relatively shorter length can retain the ribs 124 radially closer to the frame 102 than cords having relatively longer length. In some embodiments, the cords 132 can be sized and/or positioned relative to the ribs 124 such that each of the ribs can radially expand equidistantly from the frame 102. In other embodiments, one or more of the cords 132 can be sized and/or positioned relative to the ribs 124 such that the one or more of the ribs can expand relatively more or less than at least one other rib.
The length of the cords 132 can also be sized and/or configured to control the radially-expanded configuration (e.g., shape) of the ribs 124. For example, in one particular embodiment, two axially-spaced cords 132 extending in opposing circumferential directions can be coupled to each rib 124 between the first and second end portions 128, 130 of the rib 124. The cords 132 can each have a length that is less than the straight-line distance between the point on the frame 102 to which the cords 132 are attached and the rib 124 when the rib is in the radially-expanded configuration. As such, the cords 132 can cause the rib 124 to have an “S” shape when the rib is in the radially-expanded configuration.
The location at which each of the cords 132 is attached to the ribs 124 can be configured to adjust the shape (e.g., arc) of the ribs 124. In some embodiments, the location at which each of the cords 132 is attached to the ribs 124 can be configured such that the shape of each of the ribs is the same when the prosthetic heart valve 100 is in the radially-expanded configuration. In other embodiments, the location at which one or more of the cords 132 is attached to the ribs 124 can be configured such that the shape of the one or more ribs is different than at least one other rib when the prosthetic heart valve 100 is in the radially-expanded configuration.
In lieu of or in addition to the cords 132, the ribs 124 can be shape-set in the desired configuration. In such embodiments, the ribs 124 can be formed from a shape-memory material such as nitinol.
The prosthetic heart valve 100 can be releasably coupled to a delivery apparatus and crimped to the radially-compressed configuration. Although not shown, the prosthetic heart valve 100 can include an actuation mechanism that is coupled to the frame 102 of the prosthetic heart valve 100 and that, in cooperation with the delivery apparatus, is configured to incrementally move the prosthetic heart valve between the radially-compressed and radially-expanded configurations. Additional details regarding the actuation mechanism and the delivery apparatus can be found, for example, in U.S. Application No. 62/430,810 and U.S. Patent Application Publication No. 2018/0153689.
In the radially-compressed configuration, the prosthetic heart valve 100 can be advanced percutaneously to a patient's heart and positioned in the annulus of a native valve. The prosthetic heart valve 100 can be expanded from the radially-compressed configuration to the radially-expanded configuration.
In the radially-expanded configuration, the sealing member 108 can engage the tissue of the native annulus adjacent the prosthetic heart valve 100 and fill in any gaps that may exist between the frame 102 of the prosthetic heart valve 100 and the native annulus. In this manner, the sealing member 108 can, for example, reduce and/or prevent blood from flowing around the prosthetic heart valve 100 between frame 102 and the native annulus.
For example,
The prosthetic heart valve 100 can be secured within the native annulus and released from the delivery apparatus. After the prosthetic heart valve 100 is released, the sealing member 108 can continue to reduce and/or prevent PVL.
The ribs 302, the first drapes 304, and the cords 306 can, for example, be configured similar to the ribs 124, the drapes 126, and the cords 132 of the prosthetic heart valve 100, respectively.
The second drapes 308 can be coupled to and extend circumferentially between adjacent pairs of the ribs 302. The second drapes 308 can also be coupled to extend radially outwardly from the skirt 106. In this manner, the second drapes 308 can, for example, provide an additional and/or alternative means for reducing and/or eliminating PVL than the first drapes 304.
In embodiments in which the sealing member 300 includes the cords 306, the second drapes 308 can extend in a plane defined by the cords 306. In other such embodiments or embodiment in which the sealing member 300 does not include the cords 306, the second drapes 308 can extend in various other planes.
In particular embodiments, the second drapes 308 can extend from the skirt 106 in planes that are at least approximately parallel to a plane perpendicular to the longitudinal axis of the prosthetic heart valve 100. In other embodiments, the second drapes 308 can extend from the skirt 106 in planes that are at angled relative to a plane perpendicular to the longitudinal axis of the prosthetic heart valve 100. For example, is some embodiments, the second drapes 308 can define a plane that is angled approximately 10-80 degrees relative to a plane perpendicular to the longitudinal axis of the prosthetic heart valve 100. In particular embodiments, the second drapes 308 can define a plane that is angled approximately 25-65 degrees or approximately 45 degrees relative to a plane perpendicular to the longitudinal axis of the prosthetic heart valve 100.
The second drapes 308 can be coupled to the ribs 302 and/or the skirt 106 in various ways. For example, the drapes 126 can be coupled to the ribs 302 and the skirt 106 with fasteners, sutures, adhesive, ultrasonic welding, and/or other suitable means for coupling.
The second drapes 308 can comprise a flexible fabric or material configured to occlude or restrict blood flow, including PET, PTFE, ePTFE, polyurethane, and/or polyester. In some embodiments, the second drapes 308 can be formed from the same material as the first drapes 304 and/or the skirt 106 (e.g., PET). In other embodiments, at least one of the first drapes 304, the second drapes 308, and the skirt 106 can be formed from different materials. For example, the second drapes 308 can be formed from PTFE and the skirt 106 can be formed from polyester, or vice versa.
In some embodiments, the sealing member 408 can be configured similar to the sealing member 108 of the prosthetic heart valve 100. The sealing member 408 can comprise ribs 410 coupled to the frame 402 and drapes 412 extending radially outwardly between skirt 406 and the ribs 410.
In certain embodiments, the sealing member 408 can comprise cords that are coupled to and extend between the ribs 410 and the frame 402. For example, the cords can be configured similar to the cords 306 of the sealing member 300.
In particular embodiments, the drapes 412 of the sealing member 408 can be first drapes, and the sealing member can further comprise second drapes. For example, the first and second drapes of the sealing member 408 can be configured similar to the first and second drapes 304, 308 of the sealing member 300, respectively.
The features described herein regarding any example can be combined with other features described in any one or more of the other examples, unless otherwise stated. For example, the features of the sealing member 108 can be combined with the sealing member 300 and/or the sealing member 408, or vice versa. Additionally, any feature of an embodiment is independent from other components of the embodiment, unless otherwise stated.
In view of the many possible embodiments to which the principles of the disclosure may be applied, it should be recognized that the illustrated embodiments are only examples and should not be taken as limiting the scope of the claimed subject matter. Rather, the scope of the claimed subject matter is defined by the following claims and their equivalents.
This application claims the benefit of U.S. Application No. 62/554,933, filed Sep. 6, 2017, which application is incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
3409013 | Berry | Nov 1968 | A |
3548417 | Kisher | Dec 1970 | A |
3587115 | Shiley | Jun 1971 | A |
3657744 | Ersek | Apr 1972 | A |
3671979 | Moulopoulos | Jun 1972 | A |
3714671 | Edwards et al. | Feb 1973 | A |
3755823 | Hancock | Sep 1973 | A |
4035849 | Angell et al. | Jul 1977 | A |
4056854 | Boretos et al. | Nov 1977 | A |
4106129 | Carpentier et al. | Aug 1978 | A |
4222126 | Boretos et al. | Sep 1980 | A |
4265694 | Boretos et al. | May 1981 | A |
4297749 | Davis et al. | Nov 1981 | A |
RE30912 | Hancock | Apr 1982 | E |
4339831 | Johnson | Jul 1982 | A |
4343048 | Ross et al. | Aug 1982 | A |
4345340 | Rosen | Aug 1982 | A |
4373216 | Klawitter | Feb 1983 | A |
4406022 | Roy | Sep 1983 | A |
4441216 | Ionescu et al. | Apr 1984 | A |
4470157 | Love | Sep 1984 | A |
4535483 | Klawitter et al. | Aug 1985 | A |
4574803 | Storz | Mar 1986 | A |
4592340 | Boyles | Jun 1986 | A |
4605407 | Black et al. | Aug 1986 | A |
4612011 | Kautzky | Sep 1986 | A |
4643732 | Pietsch et al. | Feb 1987 | A |
4655771 | Wallsten | Apr 1987 | A |
4692164 | Dzemeshkevich et al. | Sep 1987 | A |
4733665 | Palmaz | Mar 1988 | A |
4759758 | Gabbay | Jul 1988 | A |
4762128 | Rosenbluth | Aug 1988 | A |
4777951 | Cribier et al. | Oct 1988 | A |
4787899 | Lazarus | Nov 1988 | A |
4787901 | Baykut | Nov 1988 | A |
4796629 | Grayzel | Jan 1989 | A |
4820299 | Philippe et al. | Apr 1989 | A |
4829990 | Thuroff et al. | May 1989 | A |
4851001 | Taheri | Jul 1989 | A |
4856516 | Hillstead | Aug 1989 | A |
4878495 | Grayzel | Nov 1989 | A |
4878906 | Lindemann et al. | Nov 1989 | A |
4883458 | Shiber | Nov 1989 | A |
4922905 | Strecker | May 1990 | A |
4966604 | Reiss | Oct 1990 | A |
4979939 | Shiber | Dec 1990 | A |
4986830 | Owens et al. | Jan 1991 | A |
4994077 | Dobben | Feb 1991 | A |
5007896 | Shiber | Apr 1991 | A |
5026366 | Leckrone | Jun 1991 | A |
5032128 | Alonso | Jul 1991 | A |
5037434 | Lane | Aug 1991 | A |
5047041 | Samuels | Sep 1991 | A |
5059177 | Towne et al. | Oct 1991 | A |
5080668 | Bolz et al. | Jan 1992 | A |
5085635 | Cragg | Feb 1992 | A |
5089015 | Ross | Feb 1992 | A |
5152771 | Sabbaghian et al. | Oct 1992 | A |
5163953 | Vince | Nov 1992 | A |
5167628 | Boyles | Dec 1992 | A |
5192297 | Hull | Mar 1993 | A |
5266073 | Wall | Nov 1993 | A |
5282847 | Trescony et al. | Feb 1994 | A |
5295958 | Shturman | Mar 1994 | A |
5332402 | Teitelbaum | Jul 1994 | A |
5360444 | Kusuhara | Nov 1994 | A |
5370685 | Stevens | Dec 1994 | A |
5397351 | Pavcnik et al. | Mar 1995 | A |
5411055 | Kane | May 1995 | A |
5411552 | Andersen et al. | May 1995 | A |
5443446 | Shturman | Aug 1995 | A |
5480424 | Cox | Jan 1996 | A |
5500014 | Quijano et al. | Mar 1996 | A |
5545209 | Roberts et al. | Aug 1996 | A |
5545214 | Stevens | Aug 1996 | A |
5549665 | Vesely et al. | Aug 1996 | A |
5554185 | Block et al. | Sep 1996 | A |
5558644 | Boyd et al. | Sep 1996 | A |
5571175 | Vanney et al. | Nov 1996 | A |
5584803 | Stevens et al. | Dec 1996 | A |
5591185 | Kilmer et al. | Jan 1997 | A |
5591195 | Taheri et al. | Jan 1997 | A |
5607464 | Trescony et al. | Mar 1997 | A |
5609626 | Quijano et al. | Mar 1997 | A |
5628792 | Lentell | May 1997 | A |
5639274 | Fischell et al. | Jun 1997 | A |
5665115 | Cragg | Sep 1997 | A |
5716417 | Girard et al. | Feb 1998 | A |
5728068 | Leone et al. | Mar 1998 | A |
5749890 | Shaknovich | May 1998 | A |
5756476 | Epstein et al. | May 1998 | A |
5769812 | Stevens et al. | Jun 1998 | A |
5800508 | Goicoechea et al. | Sep 1998 | A |
5840081 | Andersen et al. | Nov 1998 | A |
5855597 | Jayaraman | Jan 1999 | A |
5855601 | Bessler et al. | Jan 1999 | A |
5855602 | Angell | Jan 1999 | A |
5925063 | Khosravi | Jul 1999 | A |
5957949 | Leonhardt et al. | Sep 1999 | A |
6027525 | Suh et al. | Feb 2000 | A |
6132473 | Williams et al. | Oct 2000 | A |
6168614 | Andersen et al. | Jan 2001 | B1 |
6171335 | Wheatley et al. | Jan 2001 | B1 |
6174327 | Mertens et al. | Jan 2001 | B1 |
6210408 | Chandrasekaran et al. | Apr 2001 | B1 |
6217585 | Houser et al. | Apr 2001 | B1 |
6221091 | Khosravi | Apr 2001 | B1 |
6231602 | Carpentier et al. | May 2001 | B1 |
6245102 | Jayaraman | Jun 2001 | B1 |
6299637 | Shaolian et al. | Oct 2001 | B1 |
6302906 | Goicoechea et al. | Oct 2001 | B1 |
6338740 | Carpentier | Jan 2002 | B1 |
6350277 | Kocur | Feb 2002 | B1 |
6352547 | Brown et al. | Mar 2002 | B1 |
6425916 | Garrison et al. | Jul 2002 | B1 |
6440764 | Focht et al. | Aug 2002 | B1 |
6454799 | Schreck | Sep 2002 | B1 |
6458153 | Bailey et al. | Oct 2002 | B1 |
6461382 | Cao | Oct 2002 | B1 |
6468660 | Ogle et al. | Oct 2002 | B2 |
6482228 | Norred | Nov 2002 | B1 |
6488704 | Connelly et al. | Dec 2002 | B1 |
6527979 | Constantz et al. | Mar 2003 | B2 |
6569196 | Vesely | May 2003 | B1 |
6582462 | Andersen et al. | Jun 2003 | B1 |
6605112 | Moll et al. | Aug 2003 | B1 |
6652578 | Bailey et al. | Nov 2003 | B2 |
6689123 | Pinchasik | Feb 2004 | B2 |
6716244 | Klaco | Apr 2004 | B2 |
6730118 | Spenser et al. | May 2004 | B2 |
6733525 | Yang et al. | May 2004 | B2 |
6767362 | Schreck | Jul 2004 | B2 |
6769161 | Brown et al. | Aug 2004 | B2 |
6783542 | Eidenschink | Aug 2004 | B2 |
6830584 | Seguin | Dec 2004 | B1 |
6878162 | Bales et al. | Apr 2005 | B2 |
6893460 | Spenser et al. | May 2005 | B2 |
6908481 | Cribier | Jun 2005 | B2 |
6936067 | Buchanan | Aug 2005 | B2 |
7018406 | Seguin et al. | Mar 2006 | B2 |
7018408 | Bailey et al. | Mar 2006 | B2 |
7096554 | Austin et al. | Aug 2006 | B2 |
7225518 | Eidenschink et al. | Jun 2007 | B2 |
7276078 | Spenser et al. | Oct 2007 | B2 |
7276084 | Yang et al. | Oct 2007 | B2 |
7316710 | Cheng et al. | Jan 2008 | B1 |
7318278 | Zhang et al. | Jan 2008 | B2 |
7374571 | Pease et al. | May 2008 | B2 |
7393360 | Spenser et al. | Jul 2008 | B2 |
7462191 | Spenser et al. | Dec 2008 | B2 |
7510575 | Spenser et al. | Mar 2009 | B2 |
7563280 | Anderson et al. | Jul 2009 | B2 |
7585321 | Cribier | Sep 2009 | B2 |
7618446 | Andersen et al. | Nov 2009 | B2 |
7618447 | Case et al. | Nov 2009 | B2 |
7655034 | Mitchell et al. | Feb 2010 | B2 |
7785366 | Maurer et al. | Aug 2010 | B2 |
7959665 | Pienknagura | Jun 2011 | B2 |
7959672 | Salahieh et al. | Jun 2011 | B2 |
7993394 | Hariton et al. | Aug 2011 | B2 |
8029556 | Rowe | Oct 2011 | B2 |
8075611 | Millwee et al. | Dec 2011 | B2 |
8128686 | Paul, Jr. et al. | Mar 2012 | B2 |
8167932 | Bourang et al. | May 2012 | B2 |
8291570 | Eidenschink et al. | Oct 2012 | B2 |
8348998 | Pintor et al. | Jan 2013 | B2 |
8449606 | Eliasen et al. | May 2013 | B2 |
8454685 | Hariton et al. | Jun 2013 | B2 |
8652203 | Quadri et al. | Feb 2014 | B2 |
8747463 | Fogarty et al. | Jun 2014 | B2 |
9078781 | Ryan et al. | Jul 2015 | B2 |
20010021872 | Bailey et al. | Sep 2001 | A1 |
20020026094 | Roth | Feb 2002 | A1 |
20020032481 | Gabbay | Mar 2002 | A1 |
20020138135 | Duerig et al. | Sep 2002 | A1 |
20020143390 | Ishii | Oct 2002 | A1 |
20020173842 | Buchanan | Nov 2002 | A1 |
20030014105 | Cao | Jan 2003 | A1 |
20030050694 | Yang et al. | Mar 2003 | A1 |
20030100939 | Yodfat et al. | May 2003 | A1 |
20030158597 | Quiachon et al. | Aug 2003 | A1 |
20030212454 | Scott et al. | Nov 2003 | A1 |
20040024452 | Kruse et al. | Feb 2004 | A1 |
20040039436 | Spenser et al. | Feb 2004 | A1 |
20040078074 | Anderson et al. | Apr 2004 | A1 |
20040186558 | Pavcnik et al. | Sep 2004 | A1 |
20040186563 | Lobbi | Sep 2004 | A1 |
20040186565 | Schreck | Sep 2004 | A1 |
20040260389 | Case et al. | Dec 2004 | A1 |
20050010285 | Lambrecht et al. | Jan 2005 | A1 |
20050075725 | Rowe | Apr 2005 | A1 |
20050075728 | Nguyen et al. | Apr 2005 | A1 |
20050096736 | Osse et al. | May 2005 | A1 |
20050096738 | Cali et al. | May 2005 | A1 |
20050188525 | Weber et al. | Sep 2005 | A1 |
20050203614 | Forster et al. | Sep 2005 | A1 |
20050203617 | Forster et al. | Sep 2005 | A1 |
20050234546 | Nugent et al. | Oct 2005 | A1 |
20060004469 | Sokel | Jan 2006 | A1 |
20060025857 | Bergheim et al. | Feb 2006 | A1 |
20060058872 | Salahieh et al. | Mar 2006 | A1 |
20060074484 | Huber | Apr 2006 | A1 |
20060108090 | Ederer et al. | May 2006 | A1 |
20060149350 | Patel et al. | Jul 2006 | A1 |
20060183383 | Asmus et al. | Aug 2006 | A1 |
20060229719 | Marquez et al. | Oct 2006 | A1 |
20060259136 | Nguyen et al. | Nov 2006 | A1 |
20060259137 | Artof et al. | Nov 2006 | A1 |
20060287717 | Rowe et al. | Dec 2006 | A1 |
20070005131 | Taylor | Jan 2007 | A1 |
20070010876 | Salahieh et al. | Jan 2007 | A1 |
20070010877 | Salahieh et al. | Jan 2007 | A1 |
20070112422 | Dehdashtian | May 2007 | A1 |
20070162102 | Ryan et al. | Jul 2007 | A1 |
20070203503 | Salahieh et al. | Aug 2007 | A1 |
20070203575 | Forster et al. | Aug 2007 | A1 |
20070203576 | Lee et al. | Aug 2007 | A1 |
20070208550 | Cao et al. | Sep 2007 | A1 |
20070213813 | Von Segesser et al. | Sep 2007 | A1 |
20070233228 | Eberhardt et al. | Oct 2007 | A1 |
20070260305 | Drews et al. | Nov 2007 | A1 |
20070265700 | Eliasen et al. | Nov 2007 | A1 |
20080021546 | Patz et al. | Jan 2008 | A1 |
20080114442 | Mitchell et al. | May 2008 | A1 |
20080125853 | Bailey et al. | May 2008 | A1 |
20080154355 | Benichou et al. | Jun 2008 | A1 |
20080183271 | Frawley et al. | Jul 2008 | A1 |
20080208327 | Rowe | Aug 2008 | A1 |
20080243245 | Thambar et al. | Oct 2008 | A1 |
20080255660 | Guyenot et al. | Oct 2008 | A1 |
20080275537 | Limon | Nov 2008 | A1 |
20080294248 | Yang et al. | Nov 2008 | A1 |
20090099653 | Suri et al. | Apr 2009 | A1 |
20090118826 | Khaghani | May 2009 | A1 |
20090125118 | Gong | May 2009 | A1 |
20090157175 | Benichou | Jun 2009 | A1 |
20090276040 | Rowe et al. | Nov 2009 | A1 |
20090281619 | Le et al. | Nov 2009 | A1 |
20090287296 | Manasse | Nov 2009 | A1 |
20090287299 | Tabor et al. | Nov 2009 | A1 |
20090299452 | Eidenschink et al. | Dec 2009 | A1 |
20090319037 | Rowe et al. | Dec 2009 | A1 |
20100049313 | Alon et al. | Feb 2010 | A1 |
20100082094 | Quadri et al. | Apr 2010 | A1 |
20100168844 | Toomes et al. | Jul 2010 | A1 |
20100185277 | Braido et al. | Jul 2010 | A1 |
20100198347 | Zakay et al. | Aug 2010 | A1 |
20100204781 | Alkhatib | Aug 2010 | A1 |
20110015729 | Jimenez et al. | Jan 2011 | A1 |
20110022157 | Essinger et al. | Jan 2011 | A1 |
20110066224 | White | Mar 2011 | A1 |
20110137397 | Chau et al. | Jun 2011 | A1 |
20110218619 | Benichou et al. | Sep 2011 | A1 |
20110319991 | Hariton et al. | Dec 2011 | A1 |
20120089223 | Nguyen et al. | Apr 2012 | A1 |
20120101571 | Thambar et al. | Apr 2012 | A1 |
20120123529 | Levi et al. | May 2012 | A1 |
20120259409 | Nguyen et al. | Oct 2012 | A1 |
20130023985 | Khairkhahan et al. | Jan 2013 | A1 |
20130046373 | Cartledge et al. | Feb 2013 | A1 |
20130150956 | Yohanan et al. | Jun 2013 | A1 |
20130166017 | Cartledge et al. | Jun 2013 | A1 |
20130190857 | Mitra et al. | Jul 2013 | A1 |
20130274873 | Delaloye et al. | Oct 2013 | A1 |
20130304200 | McLean et al. | Nov 2013 | A1 |
20130310926 | Hariton | Nov 2013 | A1 |
20130317598 | Rowe et al. | Nov 2013 | A1 |
20130331929 | Mitra et al. | Dec 2013 | A1 |
20140194981 | Menk et al. | Jul 2014 | A1 |
20140200661 | Pintor et al. | Jul 2014 | A1 |
20140209238 | Bonyuet et al. | Jul 2014 | A1 |
20140222136 | Geist et al. | Aug 2014 | A1 |
20140236287 | Clague et al. | Aug 2014 | A1 |
20140277417 | Schraut et al. | Sep 2014 | A1 |
20140277419 | Garde et al. | Sep 2014 | A1 |
20140277424 | Oslund | Sep 2014 | A1 |
20140277563 | White | Sep 2014 | A1 |
20140296962 | Cartledge et al. | Oct 2014 | A1 |
20140330372 | Weston et al. | Nov 2014 | A1 |
20140343670 | Bakis et al. | Nov 2014 | A1 |
20140343671 | Yohanan et al. | Nov 2014 | A1 |
20140350667 | Braido et al. | Nov 2014 | A1 |
20150073545 | Braido | Mar 2015 | A1 |
20150073546 | Braido | Mar 2015 | A1 |
20150135506 | White | May 2015 | A1 |
20150157455 | Hoang et al. | Jun 2015 | A1 |
20160361160 | Braido et al. | Dec 2016 | A1 |
20170014229 | Nguyen-Thien-Nhon et al. | Jan 2017 | A1 |
20170143485 | Gorman, III et al. | May 2017 | A1 |
20180028310 | Gurovich et al. | Feb 2018 | A1 |
20180153689 | Maimon et al. | Jun 2018 | A1 |
20180325665 | Gurovich et al. | Nov 2018 | A1 |
20180344456 | Barash et al. | Dec 2018 | A1 |
Number | Date | Country |
---|---|---|
103705315 | Oct 2015 | CN |
2246526 | Mar 1973 | DE |
0144167 | Jun 1985 | DE |
19532846 | Mar 1997 | DE |
19546692 | Jun 1997 | DE |
19857887 | Jul 2000 | DE |
19907646 | Aug 2000 | DE |
10049812 | Apr 2002 | DE |
10049813 | Apr 2002 | DE |
10049814 | Apr 2002 | DE |
10049815 | Apr 2002 | DE |
0103546 | Mar 1984 | EP |
0850607 | Jul 1998 | EP |
1057460 | Dec 2000 | EP |
1088529 | Apr 2001 | EP |
1570809 | Sep 2005 | EP |
2788217 | Jul 2000 | FR |
2815844 | May 2002 | FR |
2056023 | Mar 1981 | GB |
1271508 | Nov 1986 | SU |
9117720 | Nov 1991 | WO |
9217118 | Oct 1992 | WO |
9301768 | Feb 1993 | WO |
9724080 | Jul 1997 | WO |
9829057 | Jul 1998 | WO |
9930646 | Jun 1999 | WO |
9933414 | Jul 1999 | WO |
0018333 | Apr 2000 | WO |
0041652 | Jul 2000 | WO |
0135878 | May 2001 | WO |
0149213 | Jul 2001 | WO |
0154624 | Aug 2001 | WO |
0154625 | Aug 2001 | WO |
0162189 | Aug 2001 | WO |
0047139 | Sep 2001 | WO |
0164137 | Sep 2001 | WO |
0176510 | Oct 2001 | WO |
0222054 | Mar 2002 | WO |
0236048 | May 2002 | WO |
0241789 | May 2002 | WO |
0243620 | Jun 2002 | WO |
0247575 | Jun 2002 | WO |
0249540 | Jun 2002 | WO |
03047468 | Jun 2003 | WO |
2005034812 | Apr 2005 | WO |
2005055883 | Jun 2005 | WO |
2005084595 | Sep 2005 | WO |
2006005015 | Jan 2006 | WO |
2006014233 | Feb 2006 | WO |
2006032051 | Mar 2006 | WO |
2006034008 | Mar 2006 | WO |
2006111391 | Oct 2006 | WO |
2006127089 | Nov 2006 | WO |
2006138173 | Dec 2006 | WO |
2005102015 | Apr 2007 | WO |
2007047488 | Apr 2007 | WO |
2007067942 | Jun 2007 | WO |
2007097983 | Aug 2007 | WO |
2008005405 | Jan 2008 | WO |
2008015257 | Feb 2008 | WO |
2008035337 | Mar 2008 | WO |
2008091515 | Jul 2008 | WO |
2008147964 | Dec 2008 | WO |
2008150529 | Dec 2008 | WO |
2009033469 | Mar 2009 | WO |
2009042196 | Apr 2009 | WO |
2009053497 | Apr 2009 | WO |
2009061389 | May 2009 | WO |
2009116041 | Sep 2009 | WO |
2009149462 | Dec 2009 | WO |
2010011699 | Jan 2010 | WO |
2010121076 | Oct 2010 | WO |
2013106585 | Jul 2013 | WO |
2015085218 | Jun 2015 | WO |
Entry |
---|
H.R. Andersen, et al. “Transluminal Implantation of Artificial Heart Valve. Description of a New Expandable Aortic Valve and Initial Results with implantation by Catheter Technique in Closed Chest Pig,” European Heart Journal, No. 13. pp. 704-708. 1992. |
H.R. Andersen “History of Percutaneous Aortic Valve Prosthesis,” Herz No. 34. pp. 343-346. 2009. |
Pavcnik, et al. “Development and initial Experimental Evaluation of a Prosthetic Aortic Valve for Transcatheter Placement,” Cardiovascular Radiology, vol. 183, No. 1. pp. 151-154. 1992. |
Bailey, S. “Percutaneous Expandable Prosthetic Valves,” Textbook of Interventional Cardiology vol. 2, 2nd Ed. pp. 1268-1276. 1994. |
Al-Khaja, et al. “Eleven Years' Experience with Carpentier-Edwards Biological Valves in Relation to Survival and Complications,” European Journal of Cardiothoracic Surgery, vol. 3. pp. 305-311. 1989. |
Ross, “Aortic Valve Surgery,” At a meeting of the Council on Aug. 4, 1966. pp. 192-197. |
Sabbah, et al. “Mechanical Factors in the Degeneration of Porcine Bioprosthetic Valves: an Overview,” Journal of Cardiac Surgery, vol. 4, No. 4. pp. 302-309. 1989. |
Wheatley, “Valve Prostheses,” Operative Surgery, 4th ed. pp. 415-424. 1986. |
Uchida, “Modifications of Gianturco Expandable Wire Stents,” American Journal of Roentgenology, vol. 150. pp. 1185-1187. 1986. |
Number | Date | Country | |
---|---|---|---|
20190069995 A1 | Mar 2019 | US |
Number | Date | Country | |
---|---|---|---|
62554933 | Sep 2017 | US |